nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C19—Prednisone—psoriatic arthritis	0.121	0.186	CbGbCtD
Guanfacine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0962	0.149	CbGbCtD
Guanfacine—CYP2C19—Dexamethasone—psoriatic arthritis	0.0753	0.116	CbGbCtD
Guanfacine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0729	0.113	CbGbCtD
Guanfacine—CYP2C9—Dexamethasone—psoriatic arthritis	0.0626	0.0968	CbGbCtD
Guanfacine—CYP3A4—Betamethasone—psoriatic arthritis	0.0626	0.0968	CbGbCtD
Guanfacine—CYP3A4—Prednisolone—psoriatic arthritis	0.0617	0.0955	CbGbCtD
Guanfacine—CYP3A4—Prednisone—psoriatic arthritis	0.0583	0.0902	CbGbCtD
Guanfacine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0364	0.0563	CbGbCtD
Guanfacine—Weight increased—Prednisone—psoriatic arthritis	0.0011	0.00312	CcSEcCtD
Guanfacine—Vision blurred—Prednisolone—psoriatic arthritis	0.0011	0.0031	CcSEcCtD
Guanfacine—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00108	0.00306	CcSEcCtD
Guanfacine—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00108	0.00305	CcSEcCtD
Guanfacine—Visual impairment—Betamethasone—psoriatic arthritis	0.00107	0.00304	CcSEcCtD
Guanfacine—Visual impairment—Dexamethasone—psoriatic arthritis	0.00107	0.00304	CcSEcCtD
Guanfacine—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00107	0.00302	CcSEcCtD
Guanfacine—Myocardial infarction—Prednisone—psoriatic arthritis	0.00106	0.003	CcSEcCtD
Guanfacine—Malaise—Prednisolone—psoriatic arthritis	0.00105	0.00297	CcSEcCtD
Guanfacine—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00105	0.00296	CcSEcCtD
Guanfacine—Vertigo—Prednisolone—psoriatic arthritis	0.00104	0.00296	CcSEcCtD
Guanfacine—Syncope—Prednisolone—psoriatic arthritis	0.00104	0.00295	CcSEcCtD
Guanfacine—Eye disorder—Dexamethasone—psoriatic arthritis	0.00104	0.00295	CcSEcCtD
Guanfacine—Eye disorder—Betamethasone—psoriatic arthritis	0.00104	0.00295	CcSEcCtD
Guanfacine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00102	0.00289	CcSEcCtD
Guanfacine—Asthma—Methotrexate—psoriatic arthritis	0.00101	0.00287	CcSEcCtD
Guanfacine—Convulsion—Prednisolone—psoriatic arthritis	0.00101	0.00285	CcSEcCtD
Guanfacine—Hypertension—Prednisolone—psoriatic arthritis	0.001	0.00284	CcSEcCtD
Guanfacine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000992	0.00281	CcSEcCtD
Guanfacine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000989	0.0028	CcSEcCtD
Guanfacine—Bradycardia—Prednisone—psoriatic arthritis	0.000988	0.0028	CcSEcCtD
Guanfacine—Alopecia—Betamethasone—psoriatic arthritis	0.000984	0.00279	CcSEcCtD
Guanfacine—Alopecia—Dexamethasone—psoriatic arthritis	0.000984	0.00279	CcSEcCtD
Guanfacine—Discomfort—Prednisolone—psoriatic arthritis	0.000978	0.00277	CcSEcCtD
Guanfacine—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000971	0.00275	CcSEcCtD
Guanfacine—Hallucination—Prednisone—psoriatic arthritis	0.000965	0.00273	CcSEcCtD
Guanfacine—Malaise—Triamcinolone—psoriatic arthritis	0.000964	0.00273	CcSEcCtD
Guanfacine—Malaise—Methylprednisolone—psoriatic arthritis	0.000962	0.00272	CcSEcCtD
Guanfacine—Vertigo—Triamcinolone—psoriatic arthritis	0.00096	0.00272	CcSEcCtD
Guanfacine—Syncope—Triamcinolone—psoriatic arthritis	0.000958	0.00271	CcSEcCtD
Guanfacine—Vertigo—Methylprednisolone—psoriatic arthritis	0.000958	0.00271	CcSEcCtD
Guanfacine—Syncope—Methylprednisolone—psoriatic arthritis	0.000956	0.00271	CcSEcCtD
Guanfacine—Oedema—Prednisolone—psoriatic arthritis	0.000948	0.00268	CcSEcCtD
Guanfacine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000939	0.00266	CcSEcCtD
Guanfacine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000937	0.00265	CcSEcCtD
Guanfacine—Shock—Prednisolone—psoriatic arthritis	0.000933	0.00264	CcSEcCtD
Guanfacine—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000933	0.00264	CcSEcCtD
Guanfacine—Convulsion—Triamcinolone—psoriatic arthritis	0.000926	0.00262	CcSEcCtD
Guanfacine—Tachycardia—Prednisolone—psoriatic arthritis	0.000926	0.00262	CcSEcCtD
Guanfacine—Convulsion—Methylprednisolone—psoriatic arthritis	0.000924	0.00262	CcSEcCtD
Guanfacine—Hypertension—Triamcinolone—psoriatic arthritis	0.000923	0.00261	CcSEcCtD
Guanfacine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000921	0.00261	CcSEcCtD
Guanfacine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000917	0.0026	CcSEcCtD
Guanfacine—Myalgia—Triamcinolone—psoriatic arthritis	0.00091	0.00258	CcSEcCtD
Guanfacine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000908	0.00257	CcSEcCtD
Guanfacine—Myalgia—Methylprednisolone—psoriatic arthritis	0.000908	0.00257	CcSEcCtD
Guanfacine—Eye disorder—Prednisone—psoriatic arthritis	0.000907	0.00257	CcSEcCtD
Guanfacine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000905	0.00256	CcSEcCtD
Guanfacine—Drowsiness—Methotrexate—psoriatic arthritis	0.000903	0.00256	CcSEcCtD
Guanfacine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.0009	0.00255	CcSEcCtD
Guanfacine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.0009	0.00255	CcSEcCtD
Guanfacine—Discomfort—Triamcinolone—psoriatic arthritis	0.000899	0.00254	CcSEcCtD
Guanfacine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000897	0.00254	CcSEcCtD
Guanfacine—Dry mouth—Triamcinolone—psoriatic arthritis	0.00089	0.00252	CcSEcCtD
Guanfacine—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000878	0.00248	CcSEcCtD
Guanfacine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000877	0.00248	CcSEcCtD
Guanfacine—Immune system disorder—Prednisone—psoriatic arthritis	0.000876	0.00248	CcSEcCtD
Guanfacine—Malaise—Dexamethasone—psoriatic arthritis	0.000874	0.00248	CcSEcCtD
Guanfacine—Malaise—Betamethasone—psoriatic arthritis	0.000874	0.00248	CcSEcCtD
Guanfacine—Oedema—Triamcinolone—psoriatic arthritis	0.000872	0.00247	CcSEcCtD
Guanfacine—Vertigo—Dexamethasone—psoriatic arthritis	0.000871	0.00247	CcSEcCtD
Guanfacine—Vertigo—Betamethasone—psoriatic arthritis	0.000871	0.00247	CcSEcCtD
Guanfacine—Syncope—Betamethasone—psoriatic arthritis	0.00087	0.00246	CcSEcCtD
Guanfacine—Syncope—Dexamethasone—psoriatic arthritis	0.00087	0.00246	CcSEcCtD
Guanfacine—Sweating—Methotrexate—psoriatic arthritis	0.000866	0.00245	CcSEcCtD
Guanfacine—Shock—Triamcinolone—psoriatic arthritis	0.000858	0.00243	CcSEcCtD
Guanfacine—Insomnia—Prednisolone—psoriatic arthritis	0.000858	0.00243	CcSEcCtD
Guanfacine—Alopecia—Prednisone—psoriatic arthritis	0.000857	0.00243	CcSEcCtD
Guanfacine—Shock—Methylprednisolone—psoriatic arthritis	0.000856	0.00242	CcSEcCtD
Guanfacine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000852	0.00241	CcSEcCtD
Guanfacine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000852	0.00241	CcSEcCtD
Guanfacine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000852	0.00241	CcSEcCtD
Guanfacine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000851	0.00241	CcSEcCtD
Guanfacine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000849	0.0024	CcSEcCtD
Guanfacine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000843	0.00239	CcSEcCtD
Guanfacine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000841	0.00238	CcSEcCtD
Guanfacine—Convulsion—Dexamethasone—psoriatic arthritis	0.00084	0.00238	CcSEcCtD
Guanfacine—Convulsion—Betamethasone—psoriatic arthritis	0.00084	0.00238	CcSEcCtD
Guanfacine—Hypertension—Dexamethasone—psoriatic arthritis	0.000837	0.00237	CcSEcCtD
Guanfacine—Hypertension—Betamethasone—psoriatic arthritis	0.000837	0.00237	CcSEcCtD
Guanfacine—Myalgia—Dexamethasone—psoriatic arthritis	0.000826	0.00234	CcSEcCtD
Guanfacine—Myalgia—Betamethasone—psoriatic arthritis	0.000826	0.00234	CcSEcCtD
Guanfacine—Anxiety—Dexamethasone—psoriatic arthritis	0.000823	0.00233	CcSEcCtD
Guanfacine—Anxiety—Betamethasone—psoriatic arthritis	0.000823	0.00233	CcSEcCtD
Guanfacine—Discomfort—Betamethasone—psoriatic arthritis	0.000816	0.00231	CcSEcCtD
Guanfacine—Discomfort—Dexamethasone—psoriatic arthritis	0.000816	0.00231	CcSEcCtD
Guanfacine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000813	0.0023	CcSEcCtD
Guanfacine—Vision blurred—Prednisone—psoriatic arthritis	0.000796	0.00225	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000795	0.00225	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000793	0.00224	CcSEcCtD
Guanfacine—Oedema—Dexamethasone—psoriatic arthritis	0.000791	0.00224	CcSEcCtD
Guanfacine—Oedema—Betamethasone—psoriatic arthritis	0.000791	0.00224	CcSEcCtD
Guanfacine—Insomnia—Triamcinolone—psoriatic arthritis	0.000789	0.00223	CcSEcCtD
Guanfacine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000787	0.00223	CcSEcCtD
Guanfacine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000784	0.00222	CcSEcCtD
Guanfacine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000783	0.00222	CcSEcCtD
Guanfacine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000782	0.00221	CcSEcCtD
Guanfacine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000781	0.00221	CcSEcCtD
Guanfacine—Visual impairment—Methotrexate—psoriatic arthritis	0.000781	0.00221	CcSEcCtD
Guanfacine—Shock—Betamethasone—psoriatic arthritis	0.000779	0.0022	CcSEcCtD
Guanfacine—Shock—Dexamethasone—psoriatic arthritis	0.000779	0.0022	CcSEcCtD
Guanfacine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000778	0.0022	CcSEcCtD
Guanfacine—Agitation—Prednisone—psoriatic arthritis	0.000776	0.0022	CcSEcCtD
Guanfacine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000772	0.00219	CcSEcCtD
Guanfacine—Tachycardia—Betamethasone—psoriatic arthritis	0.000772	0.00219	CcSEcCtD
Guanfacine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000768	0.00217	CcSEcCtD
Guanfacine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000766	0.00217	CcSEcCtD
Guanfacine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000765	0.00217	CcSEcCtD
Guanfacine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000765	0.00217	CcSEcCtD
Guanfacine—Malaise—Prednisone—psoriatic arthritis	0.000762	0.00216	CcSEcCtD
Guanfacine—Vertigo—Prednisone—psoriatic arthritis	0.000759	0.00215	CcSEcCtD
Guanfacine—Eye disorder—Methotrexate—psoriatic arthritis	0.000758	0.00214	CcSEcCtD
Guanfacine—Syncope—Prednisone—psoriatic arthritis	0.000757	0.00214	CcSEcCtD
Guanfacine—Tinnitus—Methotrexate—psoriatic arthritis	0.000756	0.00214	CcSEcCtD
Guanfacine—Fatigue—Triamcinolone—psoriatic arthritis	0.000752	0.00213	CcSEcCtD
Guanfacine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00075	0.00212	CcSEcCtD
Guanfacine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000742	0.0021	CcSEcCtD
Guanfacine—Hypotension—Dexamethasone—psoriatic arthritis	0.000739	0.00209	CcSEcCtD
Guanfacine—Hypotension—Betamethasone—psoriatic arthritis	0.000739	0.00209	CcSEcCtD
Guanfacine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000732	0.00207	CcSEcCtD
Guanfacine—Convulsion—Prednisone—psoriatic arthritis	0.000732	0.00207	CcSEcCtD
Guanfacine—Hypertension—Prednisone—psoriatic arthritis	0.000729	0.00206	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000721	0.00204	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000721	0.00204	CcSEcCtD
Guanfacine—Myalgia—Prednisone—psoriatic arthritis	0.000719	0.00203	CcSEcCtD
Guanfacine—Arthralgia—Prednisone—psoriatic arthritis	0.000719	0.00203	CcSEcCtD
Guanfacine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000719	0.00203	CcSEcCtD
Guanfacine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000717	0.00203	CcSEcCtD
Guanfacine—Anxiety—Prednisone—psoriatic arthritis	0.000716	0.00203	CcSEcCtD
Guanfacine—Alopecia—Methotrexate—psoriatic arthritis	0.000716	0.00203	CcSEcCtD
Guanfacine—Insomnia—Dexamethasone—psoriatic arthritis	0.000716	0.00203	CcSEcCtD
Guanfacine—Insomnia—Betamethasone—psoriatic arthritis	0.000716	0.00203	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000712	0.00201	CcSEcCtD
Guanfacine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000711	0.00201	CcSEcCtD
Guanfacine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000711	0.00201	CcSEcCtD
Guanfacine—Discomfort—Prednisone—psoriatic arthritis	0.00071	0.00201	CcSEcCtD
Guanfacine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000699	0.00198	CcSEcCtD
Guanfacine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000697	0.00197	CcSEcCtD
Guanfacine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000697	0.00197	CcSEcCtD
Guanfacine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000691	0.00196	CcSEcCtD
Guanfacine—Oedema—Prednisone—psoriatic arthritis	0.000689	0.00195	CcSEcCtD
Guanfacine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000688	0.00195	CcSEcCtD
Guanfacine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000688	0.00195	CcSEcCtD
Guanfacine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000688	0.00195	CcSEcCtD
Guanfacine—Fatigue—Dexamethasone—psoriatic arthritis	0.000682	0.00193	CcSEcCtD
Guanfacine—Fatigue—Betamethasone—psoriatic arthritis	0.000682	0.00193	CcSEcCtD
Guanfacine—Shock—Prednisone—psoriatic arthritis	0.000678	0.00192	CcSEcCtD
Guanfacine—Tachycardia—Prednisone—psoriatic arthritis	0.000673	0.0019	CcSEcCtD
Guanfacine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000666	0.00189	CcSEcCtD
Guanfacine—Vision blurred—Methotrexate—psoriatic arthritis	0.000665	0.00188	CcSEcCtD
Guanfacine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000655	0.00185	CcSEcCtD
Guanfacine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000652	0.00185	CcSEcCtD
Guanfacine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000652	0.00185	CcSEcCtD
Guanfacine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000647	0.00183	CcSEcCtD
Guanfacine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000647	0.00183	CcSEcCtD
Guanfacine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000643	0.00182	CcSEcCtD
Guanfacine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000641	0.00181	CcSEcCtD
Guanfacine—Malaise—Methotrexate—psoriatic arthritis	0.000636	0.0018	CcSEcCtD
Guanfacine—Vertigo—Methotrexate—psoriatic arthritis	0.000634	0.00179	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000628	0.00178	CcSEcCtD
Guanfacine—Dizziness—Prednisolone—psoriatic arthritis	0.000627	0.00178	CcSEcCtD
Guanfacine—Asthenia—Triamcinolone—psoriatic arthritis	0.000626	0.00177	CcSEcCtD
Guanfacine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000626	0.00177	CcSEcCtD
Guanfacine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000626	0.00177	CcSEcCtD
Guanfacine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000624	0.00177	CcSEcCtD
Guanfacine—Insomnia—Prednisone—psoriatic arthritis	0.000623	0.00176	CcSEcCtD
Guanfacine—Paraesthesia—Prednisone—psoriatic arthritis	0.000619	0.00175	CcSEcCtD
Guanfacine—Pruritus—Triamcinolone—psoriatic arthritis	0.000617	0.00175	CcSEcCtD
Guanfacine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000616	0.00174	CcSEcCtD
Guanfacine—Convulsion—Methotrexate—psoriatic arthritis	0.000611	0.00173	CcSEcCtD
Guanfacine—Dyspepsia—Prednisone—psoriatic arthritis	0.000607	0.00172	CcSEcCtD
Guanfacine—Myalgia—Methotrexate—psoriatic arthritis	0.000601	0.0017	CcSEcCtD
Guanfacine—Chest pain—Methotrexate—psoriatic arthritis	0.000601	0.0017	CcSEcCtD
Guanfacine—Arthralgia—Methotrexate—psoriatic arthritis	0.000601	0.0017	CcSEcCtD
Guanfacine—Decreased appetite—Prednisone—psoriatic arthritis	0.000599	0.0017	CcSEcCtD
Guanfacine—Rash—Prednisolone—psoriatic arthritis	0.000598	0.00169	CcSEcCtD
Guanfacine—Dermatitis—Prednisolone—psoriatic arthritis	0.000597	0.00169	CcSEcCtD
Guanfacine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000595	0.00169	CcSEcCtD
Guanfacine—Fatigue—Prednisone—psoriatic arthritis	0.000594	0.00168	CcSEcCtD
Guanfacine—Headache—Prednisolone—psoriatic arthritis	0.000594	0.00168	CcSEcCtD
Guanfacine—Discomfort—Methotrexate—psoriatic arthritis	0.000594	0.00168	CcSEcCtD
Guanfacine—Constipation—Prednisone—psoriatic arthritis	0.000589	0.00167	CcSEcCtD
Guanfacine—Confusional state—Methotrexate—psoriatic arthritis	0.000581	0.00164	CcSEcCtD
Guanfacine—Dizziness—Triamcinolone—psoriatic arthritis	0.000577	0.00163	CcSEcCtD
Guanfacine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000575	0.00163	CcSEcCtD
Guanfacine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000568	0.00161	CcSEcCtD
Guanfacine—Asthenia—Betamethasone—psoriatic arthritis	0.000568	0.00161	CcSEcCtD
Guanfacine—Asthenia—Dexamethasone—psoriatic arthritis	0.000568	0.00161	CcSEcCtD
Guanfacine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000564	0.0016	CcSEcCtD
Guanfacine—Nausea—Prednisolone—psoriatic arthritis	0.000563	0.00159	CcSEcCtD
Guanfacine—Pruritus—Betamethasone—psoriatic arthritis	0.00056	0.00158	CcSEcCtD
Guanfacine—Pruritus—Dexamethasone—psoriatic arthritis	0.00056	0.00158	CcSEcCtD
Guanfacine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000557	0.00158	CcSEcCtD
Guanfacine—Vomiting—Triamcinolone—psoriatic arthritis	0.000555	0.00157	CcSEcCtD
Guanfacine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000553	0.00157	CcSEcCtD
Guanfacine—Rash—Triamcinolone—psoriatic arthritis	0.00055	0.00156	CcSEcCtD
Guanfacine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000549	0.00156	CcSEcCtD
Guanfacine—Rash—Methylprednisolone—psoriatic arthritis	0.000549	0.00155	CcSEcCtD
Guanfacine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000548	0.00155	CcSEcCtD
Guanfacine—Headache—Triamcinolone—psoriatic arthritis	0.000546	0.00155	CcSEcCtD
Guanfacine—Headache—Methylprednisolone—psoriatic arthritis	0.000545	0.00154	CcSEcCtD
Guanfacine—Abdominal pain—Prednisone—psoriatic arthritis	0.000545	0.00154	CcSEcCtD
Guanfacine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000541	0.00153	CcSEcCtD
Guanfacine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000541	0.00153	CcSEcCtD
Guanfacine—Hypotension—Methotrexate—psoriatic arthritis	0.000538	0.00152	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000525	0.00149	CcSEcCtD
Guanfacine—Dizziness—Dexamethasone—psoriatic arthritis	0.000523	0.00148	CcSEcCtD
Guanfacine—Dizziness—Betamethasone—psoriatic arthritis	0.000523	0.00148	CcSEcCtD
Guanfacine—Insomnia—Methotrexate—psoriatic arthritis	0.000521	0.00147	CcSEcCtD
Guanfacine—Nausea—Triamcinolone—psoriatic arthritis	0.000518	0.00147	CcSEcCtD
Guanfacine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000517	0.00146	CcSEcCtD
Guanfacine—Nausea—Methylprednisolone—psoriatic arthritis	0.000517	0.00146	CcSEcCtD
Guanfacine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000514	0.00145	CcSEcCtD
Guanfacine—Somnolence—Methotrexate—psoriatic arthritis	0.000512	0.00145	CcSEcCtD
Guanfacine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000508	0.00144	CcSEcCtD
Guanfacine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000507	0.00144	CcSEcCtD
Guanfacine—Vomiting—Dexamethasone—psoriatic arthritis	0.000503	0.00142	CcSEcCtD
Guanfacine—Vomiting—Betamethasone—psoriatic arthritis	0.000503	0.00142	CcSEcCtD
Guanfacine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000501	0.00142	CcSEcCtD
Guanfacine—Rash—Betamethasone—psoriatic arthritis	0.000499	0.00141	CcSEcCtD
Guanfacine—Rash—Dexamethasone—psoriatic arthritis	0.000499	0.00141	CcSEcCtD
Guanfacine—Dermatitis—Betamethasone—psoriatic arthritis	0.000499	0.00141	CcSEcCtD
Guanfacine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000499	0.00141	CcSEcCtD
Guanfacine—Fatigue—Methotrexate—psoriatic arthritis	0.000497	0.00141	CcSEcCtD
Guanfacine—Headache—Betamethasone—psoriatic arthritis	0.000496	0.0014	CcSEcCtD
Guanfacine—Headache—Dexamethasone—psoriatic arthritis	0.000496	0.0014	CcSEcCtD
Guanfacine—Asthenia—Prednisone—psoriatic arthritis	0.000494	0.0014	CcSEcCtD
Guanfacine—Pruritus—Prednisone—psoriatic arthritis	0.000488	0.00138	CcSEcCtD
Guanfacine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000475	0.00134	CcSEcCtD
Guanfacine—Diarrhoea—Prednisone—psoriatic arthritis	0.000472	0.00133	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000471	0.00133	CcSEcCtD
Guanfacine—Nausea—Dexamethasone—psoriatic arthritis	0.00047	0.00133	CcSEcCtD
Guanfacine—Nausea—Betamethasone—psoriatic arthritis	0.00047	0.00133	CcSEcCtD
Guanfacine—Dizziness—Prednisone—psoriatic arthritis	0.000456	0.00129	CcSEcCtD
Guanfacine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000455	0.00129	CcSEcCtD
Guanfacine—Vomiting—Prednisone—psoriatic arthritis	0.000438	0.00124	CcSEcCtD
Guanfacine—Rash—Prednisone—psoriatic arthritis	0.000435	0.00123	CcSEcCtD
Guanfacine—Dermatitis—Prednisone—psoriatic arthritis	0.000434	0.00123	CcSEcCtD
Guanfacine—Headache—Prednisone—psoriatic arthritis	0.000432	0.00122	CcSEcCtD
Guanfacine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000424	0.0012	CcSEcCtD
Guanfacine—Asthenia—Methotrexate—psoriatic arthritis	0.000413	0.00117	CcSEcCtD
Guanfacine—Nausea—Prednisone—psoriatic arthritis	0.000409	0.00116	CcSEcCtD
Guanfacine—Pruritus—Methotrexate—psoriatic arthritis	0.000408	0.00115	CcSEcCtD
Guanfacine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000394	0.00112	CcSEcCtD
Guanfacine—Dizziness—Methotrexate—psoriatic arthritis	0.000381	0.00108	CcSEcCtD
Guanfacine—Vomiting—Methotrexate—psoriatic arthritis	0.000366	0.00104	CcSEcCtD
Guanfacine—Rash—Methotrexate—psoriatic arthritis	0.000363	0.00103	CcSEcCtD
Guanfacine—Dermatitis—Methotrexate—psoriatic arthritis	0.000363	0.00103	CcSEcCtD
Guanfacine—Headache—Methotrexate—psoriatic arthritis	0.000361	0.00102	CcSEcCtD
Guanfacine—Nausea—Methotrexate—psoriatic arthritis	0.000342	0.000968	CcSEcCtD
